CoreCap Advisors’s ProPhase Labs PRPH Stock Holding History

CoreCap Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	10	–	–	﹤0.01%	3168
2026 Q1	$1	Sell	10 -710	-99%	-$257	﹤0.01%	2932
2025 Q4	$322	Buy	720 +710	+7,100%	+$2K	﹤0.01%	2761
2025 Q3	$46	Sell	10 -340	-97%	-$1.31K	﹤0.01%	2758
2025 Q2	$1.37K	Hold	350	–	–	﹤0.01%	2379
2025 Q1	$1.42K	Buy	350 +340	+3,400%	+$1.56K	﹤0.01%	2446
2024 Q4	$76	Hold	10	–	–	﹤0.01%	2784
2024 Q3	$242	Hold	10	–	–	﹤0.01%	2475
2024 Q2	$418	Hold	10	–	–	﹤0.01%	1462
2024 Q1	$647	Buy	+10	New	+$507	﹤0.01%	2293
2022 Q4	$963	Buy	+10	New	+$1.08K	﹤0.01%	2059
2022 Q3	–	Sell	-10	Closed	-$1K	–	1672
2022 Q2	$1K	Buy	+10	New	+$879	﹤0.01%	2037
2022 Q1	–	Sell	-10	Closed	-$1K	–	1676
2021 Q4	$1K	Buy	+10	New	+$622	﹤0.01%	2207

Other funds holding PRPH

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors's PRPH Position: Q2 2026 in Review

CoreCap Advisors held its ProPhase Labs (PRPH) position steady in Q2 2026 at 10 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

CoreCap Advisors first reported a position in PRPH in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.42K in Q1 2025. 2 funds tracked by Wall St. Rank hold PRPH as of Q2 2026.

CoreCap Advisors held 10 shares of ProPhase Labs worth $1 as of Q2 2026.
CoreCap Advisors left its ProPhase Labs share count unchanged in Q2 2026.
ProPhase Labs made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #3168 holding.
CoreCap Advisors first reported a position in ProPhase Labs in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's ProPhase Labs position peaked at $1.42K in Q1 2025.
2 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.